vs

Side-by-side financial comparison of Microchip Technology (MCHP) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.0× Microchip Technology). Microchip Technology runs the higher net margin — 11.0% vs 4.4%, a 6.6% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs -72.2%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs 2.8%).

Microchip Technology Incorporated is an American publicly traded semiconductor corporation that manufactures microcontroller, mixed-signal, analog, and Flash-IP integrated circuits.

MCHP vs PACS — Head-to-Head

Bigger by revenue
PACS
PACS
1.0× larger
PACS
$1.4B
$1.3B
MCHP
Growing faster (revenue YoY)
PACS
PACS
+90.6% gap
PACS
18.4%
-72.2%
MCHP
Higher net margin
MCHP
MCHP
6.6% more per $
MCHP
11.0%
4.4%
PACS
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
2.8%
MCHP

Income Statement — Q4 FY2026 vs Q4 FY2025

Metric
MCHP
MCHP
PACS
PACS
Revenue
$1.3B
$1.4B
Net Profit
$144.2M
$59.7M
Gross Margin
61.0%
Operating Margin
16.6%
7.0%
Net Margin
11.0%
4.4%
Revenue YoY
-72.2%
18.4%
Net Profit YoY
8.9%
3022.5%
EPS (diluted)
$0.21
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCHP
MCHP
PACS
PACS
Q1 26
$1.3B
Q4 25
$1.2B
$1.4B
Q3 25
$1.1B
$1.3B
Q2 25
$1.1B
$1.3B
Q1 25
$970.5M
$1.3B
Q4 24
$1.0B
$1.1B
Q3 24
$1.2B
$1.0B
Q2 24
$1.2B
$981.4M
Net Profit
MCHP
MCHP
PACS
PACS
Q1 26
$144.2M
Q4 25
$62.7M
$59.7M
Q3 25
$41.7M
$52.4M
Q2 25
$-18.6M
$51.0M
Q1 25
$-154.6M
$28.5M
Q4 24
$-53.6M
$1.9M
Q3 24
$78.4M
$15.6M
Q2 24
$129.3M
$-10.9M
Gross Margin
MCHP
MCHP
PACS
PACS
Q1 26
61.0%
Q4 25
59.6%
Q3 25
55.9%
Q2 25
53.6%
Q1 25
51.6%
Q4 24
54.7%
Q3 24
57.4%
17.1%
Q2 24
59.4%
22.3%
Operating Margin
MCHP
MCHP
PACS
PACS
Q1 26
16.6%
Q4 25
12.8%
7.0%
Q3 25
7.8%
6.4%
Q2 25
3.0%
6.2%
Q1 25
-10.3%
3.8%
Q4 24
3.0%
1.7%
Q3 24
12.6%
2.2%
Q2 24
17.7%
0.1%
Net Margin
MCHP
MCHP
PACS
PACS
Q1 26
11.0%
Q4 25
5.3%
4.4%
Q3 25
3.7%
3.9%
Q2 25
-1.7%
3.9%
Q1 25
-15.9%
2.2%
Q4 24
-5.2%
0.2%
Q3 24
6.7%
1.5%
Q2 24
10.4%
-1.1%
EPS (diluted)
MCHP
MCHP
PACS
PACS
Q1 26
$0.21
Q4 25
$0.06
$0.42
Q3 25
$0.03
$0.32
Q2 25
$-0.09
$0.31
Q1 25
$-0.29
$0.17
Q4 24
$-0.10
$-0.03
Q3 24
$0.14
$0.10
Q2 24
$0.24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCHP
MCHP
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$240.3M
$197.0M
Total DebtLower is stronger
$5.5B
$353.2M
Stockholders' EquityBook value
$6.4B
$946.8M
Total Assets
$14.4B
$5.6B
Debt / EquityLower = less leverage
0.85×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCHP
MCHP
PACS
PACS
Q1 26
$240.3M
Q4 25
$250.7M
$197.0M
Q3 25
$236.8M
$355.7M
Q2 25
$566.5M
$294.2M
Q1 25
$771.7M
$287.5M
Q4 24
$586.0M
$157.7M
Q3 24
$286.1M
$49.5M
Q2 24
$315.1M
$73.4M
Total Debt
MCHP
MCHP
PACS
PACS
Q1 26
$5.5B
Q4 25
$5.4B
$353.2M
Q3 25
$5.4B
Q2 25
$5.5B
Q1 25
$5.6B
Q4 24
$6.7B
$411.9M
Q3 24
$6.4B
Q2 24
$6.2B
Stockholders' Equity
MCHP
MCHP
PACS
PACS
Q1 26
$6.4B
Q4 25
$6.6B
$946.8M
Q3 25
$6.7B
$871.3M
Q2 25
$6.9B
$806.8M
Q1 25
$7.1B
$750.2M
Q4 24
$6.0B
$709.6M
Q3 24
$6.3B
$660.0M
Q2 24
$6.4B
$572.1M
Total Assets
MCHP
MCHP
PACS
PACS
Q1 26
$14.4B
Q4 25
$14.3B
$5.6B
Q3 25
$14.5B
$5.6B
Q2 25
$15.0B
$5.5B
Q1 25
$15.4B
$5.5B
Q4 24
$15.6B
$5.2B
Q3 24
$15.6B
$4.5B
Q2 24
$15.8B
$3.9B
Debt / Equity
MCHP
MCHP
PACS
PACS
Q1 26
0.85×
Q4 25
0.82×
0.37×
Q3 25
0.80×
Q2 25
0.80×
Q1 25
0.80×
Q4 24
1.12×
0.58×
Q3 24
1.02×
Q2 24
0.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCHP
MCHP
PACS
PACS
Operating Cash FlowLast quarter
$-3.4M
Free Cash FlowOCF − Capex
$242.8M
FCF MarginFCF / Revenue
18.5%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$871.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCHP
MCHP
PACS
PACS
Q1 26
Q4 25
$341.4M
$-3.4M
Q3 25
$88.1M
$204.8M
Q2 25
$275.6M
$52.6M
Q1 25
$205.9M
$150.2M
Q4 24
$271.5M
$64.6M
Q3 24
$43.6M
$209.2M
Q2 24
$377.1M
$34.8M
Free Cash Flow
MCHP
MCHP
PACS
PACS
Q1 26
$242.8M
Q4 25
$318.9M
Q3 25
$51.6M
Q2 25
$257.7M
Q1 25
$191.7M
Q4 24
$253.4M
Q3 24
$22.8M
Q2 24
$304.2M
FCF Margin
MCHP
MCHP
PACS
PACS
Q1 26
18.5%
Q4 25
26.9%
Q3 25
4.5%
Q2 25
24.0%
Q1 25
19.8%
Q4 24
24.7%
Q3 24
2.0%
Q2 24
24.5%
Capex Intensity
MCHP
MCHP
PACS
PACS
Q1 26
1.1%
Q4 25
1.9%
Q3 25
3.2%
Q2 25
1.7%
Q1 25
1.5%
Q4 24
1.8%
Q3 24
1.8%
Q2 24
5.9%
Cash Conversion
MCHP
MCHP
PACS
PACS
Q1 26
Q4 25
5.44×
-0.06×
Q3 25
2.11×
3.91×
Q2 25
1.03×
Q1 25
5.28×
Q4 24
33.78×
Q3 24
0.56×
13.39×
Q2 24
2.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons